Erratum

Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of the American Medical Association
Volume296
Issue number11
DOIs
StatePublished - Sep 20 2006

Fingerprint

Bupropion
Nicotinic Receptors
American Medical Association
Smoking Cessation
Randomized Controlled Trials
Placebos
Varenicline

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{6d051e9e970b447a929bf01788698145,
title = "Erratum: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))",
author = "Raymond Niaura",
year = "2006",
month = "9",
day = "20",
doi = "10.1001/jama.296.11.1355",
language = "English (US)",
volume = "296",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Erratum

T2 - Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial (Journal of the American Medical Association (2006) 296 (56-63))

AU - Niaura, Raymond

PY - 2006/9/20

Y1 - 2006/9/20

UR - http://www.scopus.com/inward/record.url?scp=33748898469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748898469&partnerID=8YFLogxK

U2 - 10.1001/jama.296.11.1355

DO - 10.1001/jama.296.11.1355

M3 - Comment/debate

VL - 296

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 11

ER -